AKT in nasopharyngeal carcinoma regulates the expression of the cell cycle regulator p27, which in turn modulates SOX2 expression 35, and AKT in esophageal cancer promotes overexpression of SOX2 and protects SOX2 from proteasomal degradation 36. The gene discussed is SOX2; the disease is esophageal cancer.